Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
LINC01550 Suppresses Colorectal Cancer via Wnt/β-Catenin Inh
2026-06-16
This study reveals that the long noncoding RNA LINC01550 is downregulated in colorectal cancer and acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway. The findings highlight LINC01550's potential as both a prognostic biomarker and a therapeutic target in colorectal cancer.
-
Mavorixafor Hydrochloride: Redefining CXCR4 Antagonist Use i
2026-06-16
Explore how Mavorixafor hydrochloride (AMD-070 hydrochloride), a potent CXCR4 antagonist, is unlocking new frontiers in ischemia research and anti-HIV strategies. This article uniquely bridges CXCR4 signaling with tissue perfusion insights, providing advanced protocol guidance and practical assay considerations for biomedical scientists.
-
GSH-Responsive MOF Nanoparticles Enhance Melanoma Therapy
2026-06-15
Hao et al. designed glutathione-responsive metal-organic framework (MOF) nanoparticles, loaded with indocyanine green (ICG) and modified with a PD-1 inhibitory peptide, for synergistic photothermal and immunotherapy in melanoma. This approach demonstrated targeted immune checkpoint blockade and potent tumor ablation, highlighting a promising direction for next-generation cancer nanomedicines.
-
SHC-1 Inhibition Uncovers CFTR Trafficking Mechanisms in Epi
2026-06-15
Barros et al. systematically dissect how SHC-1 inhibition modulates the plasma membrane abundance of the CFTR chloride channel across distinct epithelial cell models. Their work clarifies conserved and context-dependent mechanisms of CFTR trafficking, informing both cystic fibrosis research and the design of secretory diarrhea assays.
-
BnaMAPK1 Enhances Shading Tolerance in Rapeseed via Photosys
2026-06-14
This study uncovers how the mitogen-activated protein kinase BnaMAPK1 enhances shading tolerance in rapeseed by regulating photosystem II, specifically through interactions with light-harvesting complexes. These findings inform strategies for breeding stress-resilient Brassica napus and provide mechanistic insight into plant responses to low-light environments.
-
Ceramide Metabolism Drives RGNNV Replication via Autophagy M
2026-06-13
This study elucidates how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to facilitate viral replication in fish cells. By integrating global lipidomics and targeted functional assays, the authors identify ceramides—especially C16-ceramide—as key pro-viral mediators that promote autophagy, offering new mechanistic insights for antiviral strategy development.
-
PP 1 (Src Family Tyrosine Kinase Inhibitor): Precision Contr
2026-06-12
Explore how PP 1, a potent Src family tyrosine kinase inhibitor, enables unprecedented precision in dissecting immune and oncogenic signaling pathways. This article uniquely bridges advanced mechanistic insight with next-generation assay design, offering researchers actionable guidance grounded in recent machine learning breakthroughs.
-
Practical Use of DiI (DiIC18(3)) Plasma Membrane Probe
2026-06-12
DiI (DiIC18(3)) enables selective, high-contrast plasma membrane labeling in live and fixed cells, providing robust orange-red fluorescence for applications such as neuronal tracing, cell migration assays, and membrane-specific analyses. It should not be used for aqueous protocols or exclusive intracellular organelle labeling, and strict attention to solvent compatibility and membrane integrity is required for optimal results.
-
3-Bromopyruvate and Cetuximab Co-Treatment Reverses CRC Resi
2026-06-11
This study demonstrates that combining 3-bromopyruvate with cetuximab effectively overcomes cetuximab resistance in colorectal cancer by inducing autophagy-dependent ferroptosis and apoptosis. The elucidation of FOXO3a pathway modulation offers new translational avenues for targeting drug-resistant CRC.
-
ECL Chemiluminescent Substrate Kit: Hypersensitive Detection
2026-06-11
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables ultrasensitive, HRP-based chemiluminescent detection of proteins on nitrocellulose or PVDF membranes. This kit supports low picogram-level sensitivity, long signal duration, and minimal background, making it highly effective for immunoblotting detection of low-abundance proteins.
-
TG003: Cdc2-like Kinase Inhibitor for Alternative Splicing R
2026-06-10
TG003 is a nanomolar-potency Cdc2-like kinase inhibitor that enables precise modulation of alternative splicing and splice site selection. It is widely used in research on platinum resistance mechanisms and exon-skipping therapies. Benchmark studies highlight its specificity, reproducibility, and utility in both cellular and animal models.
-
Structural Insights into TRPM3 Modulation by Neurosteroids a
2026-06-10
This study reveals high-resolution cryo-EM structures of the TRPM3 ion channel in complex with neurosteroids and the anticonvulsant primidone, providing a molecular basis for TRPM3 regulation. The findings clarify how disease mutations and pharmacological agents modulate channel gating, offering pathways for developing targeted therapies for pain and neurodevelopmental disorders.
-
25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re
2026-06-09
Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC), produced by CH25H, accumulates in lysosomes of tumor-associated macrophages, activating AMPK and reprogramming metabolism to promote immunosuppression. These findings establish CH25H as a metabolic checkpoint and suggest new strategies for modulating tumor immunity.
-
iRhom2 Modulates Odorant Receptor Adaptation in Olfactory Ne
2026-06-09
Azzopardi et al. (2024) uncover a specialized role for iRhom2 in olfactory sensory neurons (OSNs), demonstrating its involvement in the regulation and adaptation of odorant receptor gene expression. Their integrative approach reveals an activity-dependent feedback loop linking olfactory stimuli, iRhom2/ADAM17 signaling, and transcriptional changes in the olfactory system.
-
MK-2206 dihydrochloride: Applied Strategies in Akt Pathway M
2026-06-08
MK-2206 dihydrochloride empowers researchers to dissect PI3K/Akt/mTOR signaling with precision, enabling advanced apoptosis and persistence assays across cancer and infectious disease models. This guide delivers actionable protocols, troubleshooting insights, and applied innovations from the latest host-pathogen research.